Direct Comparison Of Changes In Bone Density And Bone Turnover Markers In Postmenopausal Women With Low Bone Mass Treated With 6-Monthly Denosumab Or Weekly Alendronate (Fosamax (R).
ARTHRITIS AND RHEUMATISM(2008)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要